Abstract

Investigators at Children's Memorial Health Institute, Warsaw, Poland, report monozygotic twin sisters with tuberous sclerosis complex (TSC), one treated with the mTOR inhibitor everolimus since age 4 years.

Highlights

  • Investigators at Children’s Memorial Health Institute, Warsaw, Poland, report monozygotic twin sisters with tuberous sclerosis complex (TSC), one treated with the mTOR inhibitor everolimus since age 4 years

  • 8 (66.7%) were seizure-free and showed significantly higher postoperative developmental quotient (DQ) than those with seizures

  • In the seizure-free group, postoperative DQ correlated with postoperative seizure duration (p=0.01)

Read more

Summary

DEVELOPMENTAL OUTCOME FOLLOWING HEMISPHERECTOMY FOR HEMIMEGALENCEPHALY

The authors conclude that early surgical intervention for hemimegalencephaly is preferable to brain damage from repeated seizures and encephalopathy and long-term AED use. A similar conclusion was reached by investigators at the Sorbonne, Paris, France, who reviewed the literature and reports of ~600 cases in the last 30 years Hemispheric surgical procedures are considered safe and can be performed from the first month of life. Residual insular cortex and contralateral MRI abnormalities are associated with persistent postoperative seizures and lack of cognitive improvement

NEUROCUTANEOUS DISORDERS mTOR INHIBITION AND TUBEROUS SCLEROSIS PREVENTION
Findings
ATTENTION DEFICIT HYPERACTIVITY DISORDER AND EEG
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.